- Market Realist•10 hours ago
Analysts are expecting GlaxoSmithKline’s (GSK) 3Q16 revenues to rise ~18.5% to 7.3 billion pounds, based on strong product launches and improvements in the supply chain.
- Market Realist•12 hours ago
GlaxoSmithKline is set to release its 3Q16 earnings on October 26, 2016. Analysts estimate EPS of 0.29 pounds. GSK stock has risen nearly 3.2% over the last 12 months.
- The Wall Street Journal•19 hours ago
Novartis said net income increased in the third quarter thanks to proceeds from its consumer health joint venture with GlaxoSmithKline, helping to offset declining revenue and heavy investment in its new ...
GlaxoSmithKline plc (GSK)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||40.30 x 100|
|Ask||40.39 x 100|
|Day's Range||40.19 - 40.51|
|52wk Range||37.82 - 45.58|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||2,520.00|
|Avg Vol (3m)||2,688,369|
|Dividend & Yield||1.87 (4.54%)|